New pivotal trial data support effectiveness of nipocalimab for gMG
Treatment with nipocalimab in gMG patients led to significant reductions in disease severity, per top-line data from a pivotal Phase 3 trial.| Myasthenia Gravis News
Treatment with nipocalimab in gMG patients led to significant reductions in disease severity, per top-line data from a pivotal Phase 3 trial.| Myasthenia Gravis News
Columnist Shawna Barnes, who has seronegative myasthenia gravis, is happy with her treatments and sees no reason now to change them.| Myasthenia Gravis News
Margarida Maia is a science writer for Myasthenia Gravis News with a PhD in biomedical sciences. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
Category archive page for News.| Myasthenia Gravis News
Scientists have identified a set of inflammatory molecules that could be useful as biomarkers to aid in MG diagnosis and classification.| Myasthenia Gravis News
